Skip to main content
Equibles

Elmind Capital, LP

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 2052213 NEW YORK, NY
Back to UTHR Full portfolio

Position in UTHR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,127,450
-$767,250 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
2.04%
of 13F equity value
Holder Rank
#193
of 876 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Elmind Capital, LP holds $18,594,670 across 4 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (43.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
This page 		15,000 $8,127,450
2 BCRX
Biocryst Pharmaceuticals Inc
 520,000 $5,200,000
3 SUPN
Supernus Pharmaceuticals, Inc.
 70,000 $3,255,700
4 AMLX
Amylyx Pharmaceuticals, Inc.
 112,000 $2,011,520

All Filings in UTHR

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,127,450 15,000
2026-03-31 $8,894,700 15,000
2025-12-31 $5,359,750 11,000